Vox Sanguinis

Papers
(The TQCC of Vox Sanguinis is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Collecting and evaluating convalescent plasma for COVID‐19 treatment: why and how?110
ABO blood group and COVID‐19: a review on behalf of the ISBT COVID‐19 Working Group104
Inactivation of severe acute respiratory syndrome coronavirus 2 in plasma and platelet products using a riboflavin and ultraviolet light‐based photochemical treatment85
Points to consider in the preparation and transfusion of COVID‐19 convalescent plasma58
Guidance for the procurement of COVID‐19 convalescent plasma: differences between high‐ and low‐middle‐income countries39
Impact of the COVID‐19 pandemic on blood supply and demand in the WHO African Region39
Operational protocol for donation of anti‐COVID‐19 convalescent plasma in Italy34
Blood donation in times of crisis: Early insight into the impact of COVID‐19 on blood donors and their motivation to donate across European countries30
Blood group ABO polymorphism inhibits SARS‐CoV‐2 infection and affects COVID‐19 progression29
The risk to future pregnancies of transfusing Rh(D)‐negative females of childbearing potential with Rh(D)‐positive red blood cells during trauma resuscitation is dependent on their age at transfusion27
Neonatal red blood cell transfusion27
Clinical use of Convalescent Plasma in the COVID‐19 pandemic: a transfusion‐focussed gap analysis with recommendations for future research priorities26
Early experience with convalescent plasma as immunotherapy for COVID‐19 in China: Knowns and unknowns26
Research initiatives of blood services worldwide in response to the covid‐19 pandemic22
COVID‐19 convalescent plasma therapy: hit fast, hit hard!21
Washed red cells: theory and practice20
Understanding the role of therapeutic plasma exchange in COVID‐19: preliminary guidance and practices20
Use of COVID‐19 convalescent plasma in low‐ and middle‐income countries: a call for ethical principles and the assurance of quality and safety20
The protective effect of O blood type against SARS‐CoV‐2 infection19
ABO blood group and SARS‐CoV‐2 antibody response in a convalescent donor population19
Blood supply management in times of SARS‐CoV‐2 pandemic – challenges, strategies adopted, and the lessons learned from the experience of a hospital‐based blood centre18
Amotosalen and ultraviolet A light treatment efficiently inactivates severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) in human plasma18
Blood donation and the global COVID‐19 pandemic: areas for social science research18
Severe acute respiratory syndrome coronavirus‐2: implications for blood safety and sufficiency18
Non‐phthalate plasticizer DEHT preserves adequate blood component quality during storage in PVC blood bags17
International Society of Blood Transfusion survey of experiences of blood banks and transfusion services during the COVID‐19 pandemic16
Risk of future haemolytic disease of the fetus and newborn following the transfusion of Rh(D)‐positive blood products to Rh(D)‐negative children16
Evaluation of SARS‐CoV‐2 antibody titers and potency for convalescent plasma donation: a brief commentary16
Viscoelastometric versus standard coagulation tests to guide periprocedural transfusion in adults with cirrhosis: A meta‐analysis of randomized controlled trials15
Effect of HIV pre‐exposure prophylaxis (PrEP) on detection of early infection and its impact on the appropriate post‐PrEP deferral period15
Lack of association between ABO blood groups and susceptibility to SARS‐CoV‐2 infection15
Re‐introducing whole blood for transfusion: considerations for blood providers13
Blood supply sufficiency and safety management in Iran during the COVID‐19 outbreak12
HIV incidence in South African blood donors from 2012 to 2016: a comparison of estimation methods12
Complications of blood donation reported to haemovigilance systems: analysis of eleven years of international surveillance12
Estimating the risks of prehospital transfusion of D‐positive whole blood to trauma patients who are bleeding in England12
Motivation, blood donor satisfaction and intention to return during the COVID‐19 pandemic12
A pilot randomized clinical trial of cryopreserved versus liquid‐stored platelet transfusion for bleeding in cardiac surgery: The cryopreserved versus liquid plateletNew Zealand pilot tria12
Prevalence and risks of hepatitis E virus infection in blood donors from the Western Cape, South Africa11
Impact of pathogen reduction methods on immunological properties of the COVID‐19 convalescent plasma11
Blood donation by men who have sex with men: using evidence to change policy11
Assessing the inactivation capabilities of two commercially available platelet component pathogen inactivation systems: effectiveness at end of shelf life11
Exchange transfusions in severe Rh‐mediated alloimmune haemolytic disease of the foetus and newborn: a 20‐year overview on the incidence, associated risks and outcome11
International Society of Blood Transfusion Working Party on Red Cell Immunogenetics and Blood Group Terminology Report of Basel and three virtual business meetings: Update on blood group systems11
Vox Sanguinis International Forum on transfusion services' response to COVID‐19: Summary10
Clinical outcomes of cardiac surgery patients undergoing therapeutic plasma exchange for heparin‐induced thrombocytopenia10
Incidence of anti‐D alloimmunization in D‐negative individuals receiving D‐positive red blood cell transfusion: A systematic review and meta‐analysis9
Trends in blood donations, blood donors’ knowledge, practices and expectations during the COVID‐19 pandemic in Cameroon9
The international experience of bacterial screen testing of platelet components with automated microbial detection systems: An update9
Anti‐A and SARS‐CoV‐2: an intriguing association9
Iron deficiency among French whole‐blood donors: first assessment and identification of predictive factors9
Prediction and impact of personalized donation intervals9
Preservation of neutralizing antibody function in COVID‐19 convalescent plasma treated using a riboflavin and ultraviolet light‐based pathogen reduction technology9
Gender‐neutral donor deferral policies: experience in Argentina implementing individual risk‐assessment policies9
Clinical consequences of the extremely rare anti‐PP1Pk isoantibodies in pregnancy: a case series and review of the literature9
Colloid osmotic pressure of contemporary and novel transfusion products8
A discrete‐event simulation model for analysing and improving operations in a blood donation centre8
The impact of COVID‐19 outbreak on the Transfusion Medicine Unit of a Northern Italy Hospital and Cancer Centre8
The relationship of membrane stiffness, cytoskeleton structure and storage time of pRBCs8
10‐year analysis of human immunodeficiency virus incidence in first‐time and repeat donors in Brazil8
Lessons learned in the collection of convalescent plasma during the COVID‐19 pandemic8
Activity‐based cost of platelet transfusions in medical and surgical inpatients at a US hospital8
HIV residual risk in Canada for apheresis source plasma donation without deferral for men who have sex with men8
Offering new and returned donors the option to give plasma: implications for donor retention and donor adverse events8
Residual risks of bacterial contamination for pathogen‐reduced platelet components8
HLA Class II regulation of immune response in sickle cell disease patients: Susceptibility to red blood cell alloimmunization (systematic review and meta‐analysis)8
Current status of rapid bacterial detection methods for platelet components: A 20‐year review by the ISBT Transfusion‐Transmitted Infectious Diseases Working Party Subgroup on Bacteria8
Establishment of transfusion‐relevant bacteria reference strains for red blood cells8
Association of the ABO blood group with SARS‐CoV‐2 infection in a community with low infection rate8
Whole blood haemostatic function throughout a 28‐day cold storage period: an in vitro study8
Physician autonomy and patient rights: lessons from an enforced blood transfusion and the role of patient blood management7
Early packed red blood cell transfusion in major trauma patients: Evaluation and comparison of different prediction scores for massive transfusion7
ISBT 2022 ‐ Abstract Book7
Are convalescent plasma stocks collected during former COVID‐19 waves still effective against current SARS‐CoV‐2 variants?7
Impact of COVID‐19 on blood donor deferral patterns during the COVID‐19 pandemic: A retrospective analysis7
Deferasirox‐associated Fanconi syndrome in adult patients with transfusional iron overload7
Stepwise access to safe plasma proteins in resource‐constrained countries: Local production and pathways to fractionation—Report of an International Society of Blood Transfusion Workshop7
International Forum on Policies and Practice for Transfusion of ABO and RhD Non‐Identical Platelets: Summary7
Survey of blood centre readiness regarding removal of DEHP from blood bag sets: The BEST Collaborative Study7
Automated RBC Exchange has a greater effect on whole blood viscosity than manual whole blood exchange in adult patients with sickle cell disease7
Abstract7
Impact of disasters on blood donation rates and blood safety: A systematic review and meta‐analysis7
International survey of strategies to mitigate transfusion‐transmittedTrypanosoma cruzi in non‐endemic countries, 2016–20187
A case of Philadelphia chromosome‐positive acute lymphocytic leukaemia with type I CD36 deficiency6
Vox Sanguinis International Forum on Donor Incentives: Summary6
Plasma procurement and plasma product safety in light of the COVID‐19 pandemic from the perspective of the plasma industry6
Noncompliance to blood donor selection criteria by men who have sex with men – Complidon 2017, France6
Introduction of principles of blood management to healthy donor bone marrow harvesting6
Current challenges of severe acute respiratory syndrome coronavirus 2 seroprevalence studies among blood donors: A scoping review6
Blood transfusion activity in a general hospital during the COVID‐19 pandemic6
Validation of a flow‐cytometry‐based red blood cell antigen phenotyping method6
Recommendation for validation and quality assurance of non‐invasive prenatal testing for foetal blood groups and implications for IVD risk classification according to EU regulati6
Abstract6
Sequence variants in the proximal promoter and +5.8‐kb site of ABO in Koreans with weak B phenotypes6
Risk of variant Creutzfeldt–Jakob disease transmission by blood transfusion in Australia6
Use of plerixafor to mobilize haematopoietic progenitor cells in healthy donors6
The impact of donor ferritin testing on blood availability in Canada6
Preventing transfusion‐transmitted malaria in France6
Filariasis and transfusion‐associated risk: a literature review5
Polycythaemia vera: molecular genetics, diagnostics and therapeutics5
Genetic determinants of ferritin, haemoglobin levels and haemoglobin trajectories: results from Donor InSight5
Qualifying coronavirus disease 2019 convalescent plasma donors in Israel5
Hepatitis E virus is effectively inactivated in platelet concentrates by ultraviolet C light5
International Forum on the Management of Major Haemorrhage: Summary5
Lipid ratios as a marker for red blood cell storage quality and as a possible explanation for donor gender differences in storage quality5
Time–temperature indicators versus temperature indicators for transfusion practice: Application in the real hospital setting5
First annual report of Chinese haemovigilance network5
An international comparison of anti‐SARS‐COV‐2 assays used for seroprevalence surveys from blood component providers5
RAGE interacts with the necroptotic protein RIPK3 and mediates transfusion‐induced danger signal release5
Determinants of intention to return to donate blood among first‐time blood donors in Ghana5
Civilian prehospital transfusion – experiences from a French region5
The history of buffy coat platelet concentrates: The Dutch story5
Research partnerships between blood services and public health authorities: An international, cross‐sectional survey5
Does ABO blood group influence antibody response to SARS‐CoV‐2 vaccination?5
COVID‐19 convalescent plasma: Evolving strategies for serological screening in France5
Efficacy of therapeutic plasma exchange in severe COVID‐19 disease: A meta‐analysis5
An open‐source python library for detection of known and novel Kell, Duffy and Kidd variants from exome sequencing5
Determinants of the intention to participate in a programme of plasma donation for fractionation among men who have sex with men5
A novel cancer immunotherapy utilizing autologous tumour tissue5
Use of selective phenotyping and genotyping to identify rare blood donors in Canada5
International Forum on Gender Identification and Blood Collection: Summary5
How donor selection criteria can be evaluated with limited scientific evidence: lessons learned from the TRANSPOSE project5
Blood donor eligibility criteria for medical conditions: A BEST collaborative study5
Management of blood transfusion services in low‐resource countries5
Impacts of COVID‐19 and elective surgery cancellations on platelet supply and utilization in the Canadian Province of British Columbia5
Understanding the experiences of plasma donors in Canada's new source plasma collection centres during COVID‐19: A qualitative study5
Overcoming the challenges of interpreting complex and uncommon RH alleles from whole genomes5
The spectrum of ABO haemolytic disease of the fetus and newborn in neonates born to group O mothers5
High‐titre anti‐SARS‐CoV‐2 convalescent plasma donation after donors’ vaccination5
Amlodipine as adjuvant therapy to current chelating agents for reducing iron overload in thalassaemia major: a systematic review, meta‐analysis and simulation of future studies5
Preventing alloimmunization using a new model for matching extensively typed red blood cells5
Recommendations for in vitro evaluation of blood components collected, prepared and stored in non‐DEHP medical devices5
Patterns of red‐cell transfusion use in obstetric practice in Sweden 2003‐2017: A nationwide study5
ABO haemolytic disease of the newborn: Improved prediction by novel integration of causative and protective factors in newborn and mother4
Plasma collection and supply in Europe: Proceedings of an International Plasma and Fractionation Association and European Blood Alliance symposium4
Cryopreserved platelets and their suitability in being re‐suspended in additive solution4
Analysis of gender representation on transfusion medicine journal editorial boards: Comparison between 2019 and 20224
In vitro diagnostics for screening the blood supply: the new European regulation for IVD and the WHO IVD prequalification programme4
Demand and usage of unrelated donor products for allogeneic haematopoietic cell transplantation during the COVID‐19 pandemic: A Canadian Blood Services Stem Cell Registry analysis4
The new donor vigilance system in Denmark reveals regional differences in adverse reactions supposedly caused by variation in the registration4
GMP‐grade CD34+ selection from HLA‐homozygous licensed cord blood units and short‐term expansion under European ATMP regulations4
Effects of plasmapheresis frequency on health status and exercise performance in men: A randomized controlled trial4
Rapid genotyping of 508G>A (rs3745635) and 1067T>A (rs3894326) of FUT3 by a duplex Eprobe‐mediated melting curve analysis4
Single‐exon approach to non‐invasive fetal RHD screening in early pregnancy: An update after 10 years' experience4
Clinical and in vitro evaluation of red blood cells collected and stored in a non‐DEHP plasticized bag system4
Maternity iron, anaemia and blood management in South Australia: a practice‐based evidence for clinical practice improvement4
Reduced neutralizing antibody potency of COVID‐19 convalescent vaccinated plasma against SARS‐CoV‐2 Omicron variant4
Validation of a standardized donor health questionnaire across substances of human origin4
Characterization of health issues in young first‐time blood donors4
Immediate intravenous iron administration improves anaemia recovery following total knee arthroplasty: A propensity‐matched analysis4
The incremental benefit of anaerobic culture for controlling bacterial risk in platelets: a systematic review and meta‐analysis4
International Forum on the Collection and Use of COVID‐19 Convalescent Plasma: Protocols, Challenges and Lessons Learned: Summary4
Inequality averse and compassionate blood donor: implication for interventions4
Costs associated with transfusion therapy in patients with myelodysplastic syndromes in Sweden: a nationwide retrospective cohort study4
Mortality and outcomes by blood group in trauma patients: A systematic review and meta‐analysis4
Development and evaluation of stem cell collection procedure diagrams to support the education and recruitment of committed stem cell donors4
Breast milk contains red cell isohaemagglutinins: An observational study of 176 mothers4
Preference for whole blood versus plasma donation among university students4
An international comparison of HIV prevalence and incidence in blood donors and general population: a BEST Collaborative study4
DEHT is a suitable plasticizer option for phthalate‐free storage of irradiated red blood cells4
Platelet transfusion is associated with 90‐day and 1‐year mortality for adult patients requiring veno‐arterial extracorporeal membrane oxygenation4
Dose‐dependent effects of red blood cell transfusion and case mix index on venous thromboembolic events in spine surgery4
Short‐term high‐dose intravenous iron reduced peri‐operative transfusion after staggered bilateral total knee arthroplasty: A retrospective cohort study4
Safety profile of plasma for fractionation donated in the United Kingdom, with respect to variant Creutzfeldt–Jakob disease4
Application of unsupervised machine learning to identify areas of blood product wastage in transfusion medicine4
Red blood cell alloimmunization among recipients of blood transfusion in India: A systematic review and meta‐analysis4
High false discovery rate of the Architect anti‐HCV screening test in blood donors in Uganda and evaluation of an algorithm for confirmatory testing4
Serum anti‐Spike immunoglobulin G levels in random blood donors in Italy: High‐titre convalescent plasma is easier than ever to procure4
Early and out‐of‐hospital use of COVID‐19 convalescent plasma: An international assessment of utilization and feasibility4
Use of O RhD‐negative red blood cells: A nationwide, prospective audit4
White paper on pandemic preparedness in the blood supply4
Weak D type 42: Antigen density and risk of alloimmunization in the province of Québec3
Pharmacogenomics with red cells: a model to study protein variants of drug transporter genes3
Impact of restrictive red blood cell transfusion strategy on thrombosis‐related events: A meta‐analysis and systematic review3
COVID‐19 infection and complications according to ABO blood group in the elderly: A population‐based subcohort and meta‐analysis3
Frequency and timing of all‐cause deaths in visits involving suspected transfusion reactions, and the significance of cardiopulmonary disturbances3
Evolving the gay, bisexual and other men who have sex with men time‐based deferral to sexual risk screening for all donors: The contribution of Canadian research programmes3
A comparison of the effect of X and gamma irradiation on red cell storage quality3
Reported non‐compliance with pre‐donation screening among blood donors in Québec, Canada: A focus on the 3‐month deferral for men who have sex with men3
A branded bandage is worth a thousand words: blood branded bandages signal men’s generosity and morality3
Climate change: A call for action, even for Vox Sanguinis3
Efficacy and safety of a reduced dose of plerixafor in combination with granulocyte colony‐stimulating factor in healthy haploidentical stem cell donors3
Plasma, platelet and red blood cell transfusion ratios for life‐threatening non‐traumatic haemorrhage in medical and post‐surgical patients: An observational study3
Eye drops of human origin—Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies3
Effect of red blood cell transfusion on inflammation, endothelial cell activation and coagulation in the critically ill3
Impact of donor ferritin testing on iron deficiency prevention and blood availability in France: A cohort simulation study3
The impact of revised definitions for transfusion‐associated circulatory overload and transfusion‐related acute lung injury on haemovigilance reporting3
Gone, but haven't forgotten: insights on plasmapheresis donation from lapsed donors3
Ludwik Hirszfeld: A pioneer of transfusion and immunology during the world wars and beyond3
Systematic reviews on platelet transfusions: Is there unnecessary duplication of effort? A scoping review3
Low ferritin levels appear to be associated with worsened health in male repeat blood donors3
Subjects with blood group O are not at lower risk to acquire SARS‐CoV‐2 infection3
Is there an optimal trade‐off between anaemia and red blood cell transfusion in surgical critically ill patients after oncologic surgery?3
Is intravenous immunoglobulin a risk factor for necrotizing enterocolitis in neonates with haemolytic disease of the newborn? A retrospective cohort study3
Vox Sanguinis International forum on the selection and preparation of blood components for intrauterine transfusion3
TACO‐BEL‐3: a feasibility study and a retrospective audit of diuretics for patients receiving blood transfusion at ten hospitals3
An international comparison of haemoglobin deferral prediction models for blood banking3
Vox Sanguinis International Forum on the selection and preparation of blood components for intrauterine transfusion: Summary3
Profile of the single‐use, multiple‐pass protein A adsorber column in immunoadsorption3
Transfusion profile, clinical characteristics, comorbidities and outcomes of 3014 hospitalized patients diagnosed with COVID‐19 in Brazil3
International Forum on Home‐Based Blood Transfusion: Summary3
Utility of reticulocyte haemoglobin content and immature reticulocyte fraction in early diagnosis of latent iron deficiency in whole blood donors3
A randomized study of a best practice alert for platelet transfusions3
Challenging the 30‐min rule for thawed plasma3
Low‐dose prophylaxis and its impact on the health of haemophilia patients3
MATRA‐A: A study on massive transfusion3
Basophil activation test for allergic and febrile non‐haemolytic transfusion reactions among paediatric patients with haematological or oncological disease3
Plasma resuscitation improves and restores intestinal microcirculatory physiology following haemorrhagic shock3
Optimization of diagnostic strategy for non‐invasive cell‐free foetal RHD determination from maternal plasma3
Putting the spotlight on donation‐related risks and donor safety – are we succeeding in protecting donors?3
Quality assessment and harmonization of laboratories across Europe for multiple SARS‐CoV‐2 serology assays3
Evaluation of the Sysmex XN‐31 automated analyser for blood donor malaria screening at Malawi Blood Transfusion Services3
Transfusion requirements and alloimmunization to red blood cell antigens in orthotopic liver transplantation3
Blood component ratios in children with non‐traumatic life‐threatening bleeding3
Explainable haemoglobin deferral predictions using machine learning models: Interpretation and consequences for the blood supply3
The ‘rejuvenating factor’ TIMP‐2 is detectable in human blood components for transfusion3
0.095355033874512